Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.
Reshitko GS, Yamansarov EY, Evteev SA, Lopatukhina EV, Shkil' DO, Saltykova IV, Lopukhov AV, Kovalev SV, Lobov AN, Kislyakov IV, Burenina OY, Klyachko NL, Garanina AS, Dontsova OA, Ivanenkov YA, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Reshitko GS, et al. Among authors: yamansarov ey. Bioconjug Chem. 2020 May 20;31(5):1313-1319. doi: 10.1021/acs.bioconjchem.0c00202. Epub 2020 May 9. Bioconjug Chem. 2020. PMID: 32379426
New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
Petrov RA, Mefedova SR, Yamansarov EY, Maklakova SY, Grishin DA, Lopatukhina EV, Burenina OY, Lopukhov AV, Kovalev SV, Timchenko YV, Ondar EE, Ivanenkov YA, Evteev SA, Vaneev AN, Timoshenko RV, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Petrov RA, et al. Among authors: yamansarov ey. Mol Pharm. 2021 Jan 4;18(1):461-468. doi: 10.1021/acs.molpharmaceut.0c00980. Epub 2020 Dec 2. Mol Pharm. 2021. PMID: 33264010
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma.
Yamansarov EY, Lopatukhina EV, Evteev SA, Skvortsov DA, Lopukhov AV, Kovalev SV, Vaneev AN, Shkil' DO, Akasov RA, Lobov AN, Naumenko VA, Pavlova EN, Ryabaya OO, Burenina OY, Ivanenkov YA, Klyachko NL, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Yamansarov EY, et al. Bioconjug Chem. 2021 Apr 21;32(4):763-781. doi: 10.1021/acs.bioconjchem.1c00042. Epub 2021 Mar 10. Bioconjug Chem. 2021. PMID: 33691403
Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
Ivanenkov YA, Majouga AG, Petrov RA, Petrov SA, Kovalev SV, Maklakova SY, Yamansarov EY, Saltykova IV, Deyneka EV, Filkov GI, Kotelianski VE, Zatsepin TS, Beloglazkina EK. Ivanenkov YA, et al. Among authors: yamansarov ey. Bioorg Med Chem Lett. 2018 Feb 1;28(3):503-508. doi: 10.1016/j.bmcl.2017.12.004. Epub 2017 Dec 12. Bioorg Med Chem Lett. 2018. PMID: 29254645
Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
Petrov RA, Maklakova SY, Ivanenkov YA, Petrov SA, Sergeeva OV, Yamansarov EY, Saltykova IV, Kireev II, Alieva IB, Deyneka EV, Sofronova AA, Aladinskaia AV, Trofimenko AV, Yamidanov RS, Kovalev SV, Kotelianski VE, Zatsepin TS, Beloglazkina EK, Majouga AG. Petrov RA, et al. Among authors: yamansarov ey. Bioorg Med Chem Lett. 2018 Feb 1;28(3):382-387. doi: 10.1016/j.bmcl.2017.12.032. Epub 2017 Dec 14. Bioorg Med Chem Lett. 2018. PMID: 29269214